PET scans guide personalized treatment in High-Risk lymphoma trial
NCT ID NCT00498043
Summary
This study tested two different chemotherapy combinations (R-ACVBP and R-CHOP) for younger adults with aggressive B-cell lymphoma who had higher risk factors. The trial used PET scans after the 2nd and 4th treatment cycles to guide whether patients received standard consolidation therapy or more intensive treatment including stem cell transplant. The goal was to see if this scan-guided approach could better control the disease by adjusting treatment based on how well patients responded.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
René Olivier Casasnovas
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.